Payment overview · 2025
General Payments
$42.70
3 reported records · 2 companies
Healthcare provider profile · identity verified
Thomas Leon Voitier, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · LAFAYETTE, LA · NPI 1598906570
Verified facts
What the public records show
CMS Open Payments records show Thomas Leon Voitier, M.D. received $42.70 in general payments during 2025 across 3 reported records.
GlaxoSmithKline, LLC. accounted for 73.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $31.49 | 73.8% | 2 | 2025 |
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $11.21 | 26.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $42.70 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $16.18 | 1 | 2025 |
Source payment records
|
|||||
| AREXVY Normalized: arexvy |
Biological | GlaxoSmithKline, LLC. | $15.31 | 1 | 2025 |
Source payment records
|
|||||
| SHINGRIX Normalized: shingrix |
Biological | GlaxoSmithKline, LLC. | $15.31 | 1 | 2025 |
Source payment records
|
|||||
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $11.21 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 734 | 158 |
| Amlodipine Besylate | Amlodipine Besylate | 698 | 173 |
| Losartan Potassium | Losartan Potassium | 548 | 130 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 542 | 135 |
| Pantoprazole Sodium | Pantoprazole Sodium | 518 | 129 |
| Alprazolam | Alprazolam | 407 | 80 |
| Atorvastatin Calcium | Atorvastatin Calcium | 386 | 106 |
| Metoprolol Succinate | Metoprolol Succinate | 337 | 77 |
| Metformin Hcl | Metformin Hcl | 336 | 73 |
| Escitalopram Oxalate | Escitalopram Oxalate | 323 | 72 |
| Gabapentin | Gabapentin | 293 | 58 |
| Tramadol Hcl | Tramadol Hcl | 270 | 59 |
| Hydrochlorothiazide | Hydrochlorothiazide | 268 | 68 |
| Zolpidem Tartrate | Zolpidem Tartrate | 262 | 51 |
| Ozempic | Semaglutide | 256 | 45 |
| Furosemide | Furosemide | 249 | 65 |
| Omeprazole | Omeprazole | 240 | 60 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 233 | 58 |
| Trazodone Hcl | Trazodone Hcl | 206 | 46 |
| Simvastatin | Simvastatin | 200 | 54 |
| Sertraline Hcl | Sertraline Hcl | 197 | 46 |
| Alendronate Sodium | Alendronate Sodium | 195 | 51 |
| Meloxicam | Meloxicam | 186 | 61 |
| Tamsulosin Hcl | Tamsulosin Hcl | 183 | 56 |
| Pravastatin Sodium | Pravastatin Sodium | 181 | 48 |
| Fluticasone Propionate | Fluticasone Propionate | 173 | 66 |
| Lisinopril | Lisinopril | 170 | 45 |
| Carvedilol | Carvedilol | 157 | 44 |
| Allopurinol | Allopurinol | 152 | 40 |
| Duloxetine Hcl | Duloxetine Hcl | 149 | 22 |
| Eliquis | Apixaban | 146 | 25 |
| Glimepiride | Glimepiride | 133 | 35 |
| Amitriptyline Hcl | Amitriptyline Hcl | 131 | 35 |
| Famotidine | Famotidine | 129 | 33 |
| Clonazepam | Clonazepam | 126 | 17 |
| Glipizide Er | Glipizide | 126 | 35 |
| Donepezil Hcl | Donepezil Hcl | 118 | 29 |
| Synthroid | Levothyroxine Sodium | 111 | 26 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 104 | 34 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 99 | 77 |
| Jardiance | Empagliflozin | 99 | 14 |
| Valsartan | Valsartan | 99 | 22 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 92 | 70 |
| Citalopram Hbr | Citalopram Hydrobromide | 91 | 27 |
| Ropinirole Hcl | Ropinirole Hcl | 91 | 16 |
| Pioglitazone Hcl | Pioglitazone Hcl | 87 | 24 |
| Clopidogrel | Clopidogrel Bisulfate | 85 | 25 |
| Potassium Chloride | Potassium Chloride | 82 | 25 |
| Prednisone | Prednisone | 81 | 42 |
| Montelukast Sodium | Montelukast Sodium | 80 | 19 |
| Lorazepam | Lorazepam | 76 | 16 |
| Trulicity | Dulaglutide | 72 | 15 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 64 | 24 |
| Azithromycin | Azithromycin | 64 | 53 |
| Tizanidine Hcl | Tizanidine Hcl | 64 | 32 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 62 | 17 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 61 | 24 |
| Metoprolol Tartrate | Metoprolol Tartrate | 60 | 15 |
| Spironolactone | Spironolactone | 59 | 19 |
| Warfarin Sodium | Warfarin Sodium | 58 | 11 |
| Ezetimibe | Ezetimibe | 56 | 18 |
| Ondansetron Odt | Ondansetron | 56 | 41 |
| Fluoxetine Hcl | Fluoxetine Hcl | 55 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 55 | 11 |
| Azelastine Hcl | Azelastine Hcl | 51 | 29 |
| Memantine Hcl | Memantine Hcl | 51 | 12 |
| Fenofibrate | Fenofibrate | 50 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 50 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 50 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 49 | 13 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 49 | 14 |
| Mounjaro | Tirzepatide | 49 | 11 |
| Atenolol | Atenolol | 47 | 13 |
| Metformin Hcl Er | Metformin Hcl | 47 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 45 | 13 |
| Diclofenac Sodium | Diclofenac Sodium | 45 | 14 |
| Diazepam | Diazepam | 44 | 15 |
| Mirtazapine | Mirtazapine | 44 | suppressed |
| Temazepam | Temazepam | 44 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 43 | 11 |
| Celecoxib | Celecoxib | 42 | 12 |
| Finasteride | Finasteride | 40 | 12 |
| Glipizide | Glipizide | 40 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 38 | suppressed |
| Xarelto | Rivaroxaban | 36 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 35 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 34 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 34 | suppressed |
| Estradiol | Estradiol | 34 | suppressed |
| Pregabalin | Pregabalin | 34 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 34 | 26 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 33 | suppressed |
| Methylprednisolone | Methylprednisolone | 32 | 27 |
| Levetiracetam | Levetiracetam | 31 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 31 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 29 | 12 |
| Bupropion Xl | Bupropion Hcl | 28 | suppressed |
| Dexilant | Dexlansoprazole | 28 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 28 | suppressed |
| Lovastatin | Lovastatin | 28 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 27 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 27 | 16 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 26 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 25 | suppressed |
| Eszopiclone | Eszopiclone | 25 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 25 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 25 | 12 |
| Baclofen | Baclofen | 24 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 24 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 24 | suppressed |
| Fluconazole | Fluconazole | 23 | 18 |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 22 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 22 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 22 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 22 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 21 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 21 | suppressed |
| Ramipril | Ramipril | 21 | suppressed |
| Cilostazol | Cilostazol | 20 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 20 | suppressed |
| Methocarbamol | Methocarbamol | 20 | 11 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 20 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 19 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 19 | suppressed |
| Irbesartan | Irbesartan | 19 | suppressed |
| Mupirocin | Mupirocin | 19 | 16 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 19 | 15 |
| Promethazine Hcl | Promethazine Hcl | 19 | suppressed |
| Tradjenta | Linagliptin | 19 | suppressed |
| Verapamil Er | Verapamil Hcl | 19 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 18 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 18 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 18 | suppressed |
| Torsemide | Torsemide | 18 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 17 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 17 | 15 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 17 | suppressed |
| Ketoconazole | Ketoconazole | 17 | suppressed |
| Nifedipine Er | Nifedipine | 17 | suppressed |
| Anastrozole | Anastrozole | 16 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 16 | suppressed |
| Modafinil | Modafinil | 16 | suppressed |
| Ranolazine Er | Ranolazine | 16 | suppressed |
| Sucralfate | Sucralfate | 16 | suppressed |
| Betamethasone Valerate | Betamethasone Valerate | 15 | 12 |
| Doxycycline Hyclate | Doxycycline Hyclate | 15 | suppressed |
| Clonidine | Clonidine | 14 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 14 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Hydrocortisone | Hydrocortisone | 14 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 14 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 14 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 14 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 14 | 14 |
| Vilazodone Hcl | Vilazodone Hcl | 14 | suppressed |
| Amoxapine | Amoxapine | 13 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 13 | suppressed |
| Levofloxacin | Levofloxacin | 13 | 13 |
| Nadolol | Nadolol | 13 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 13 | suppressed |
| Acebutolol Hcl | Acebutolol Hcl | 12 | suppressed |
| Belsomra | Suvorexant | 12 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 12 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 12 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 12 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 12 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 12 | suppressed |
| Premarin | Estrogens, Conjugated | 12 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Vascepa | Icosapent Ethyl | 12 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Insulin Lispro | Insulin Lispro | 11 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 11 | suppressed |
| Jantoven | Warfarin Sodium | 11 | suppressed |
| Januvia | Sitagliptin Phosphate | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 11 | suppressed |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 11 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $42.70 · 3 records | GlaxoSmithKline, LLC. | AREXVY, SHINGRIX, TRELEGY ELLIPTA, VOQUEZNA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error